Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diffuse Intrinsic Pontine Glioma × Cilengitide × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 3 Specimen Handling 2 spartalizumab 1 ribociclib 1 pembrolizumab 1 lorlatinib 1 larotrectinib 1 dinutuximab 1 balstilimab 1 abemaciclib 1 Vaccines 1 Pharmacogenomic Variants 1 Pharmacogenomic Testing 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Ipilimumab 1 Immune Checkpoint Inhibitors 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fluid Therapy 1 Everolimus 1 Eflornithine 1 Diffusion Tensor Imaging 1 Cilengitide 1 CLR1404 1 CBLC137 1 Biopsy 1 ACT001 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡